|
Vivanza Biosciences Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
8.16 Cr.
|
P/BV
|
1.66
|
Book Value (Rs.)
|
1.23
|
|
52 Week High/Low (Rs.)
|
4/2
|
FV/ML
|
1/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
01/08/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | -0.17 | 0.14 | 1.50 | 0.83 | 0.19 |
| Diluted EPS (Rs.) | -0.17 | 0.14 | 1.50 | 0.83 | 0.19 |
| Cash EPS (Rs.) | -0.16 | 0.13 | 0.15 | 0.85 | 0.21 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 0.99 | 1.16 | 1.02 | 8.73 | 7.90 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 0.99 | 1.16 | 1.02 | 8.73 | 7.90 |
| Revenue From Operations / Share (Rs.) | 1.86 | 6.96 | 4.45 | 26.00 | 24.72 |
| PBDIT / Share (Rs.) | -0.07 | 0.28 | 0.28 | 1.87 | 1.50 |
| PBIT / Share (Rs.) | -0.07 | 0.27 | 0.28 | 1.85 | 1.48 |
| PBT / Share (Rs.) | -0.16 | 0.17 | 0.17 | 0.83 | 0.30 |
| Net Profit / Share (Rs.) | -0.16 | 0.13 | 0.14 | 0.83 | 0.18 |
| NP After MI And SOA / Share (Rs.) | -0.16 | 0.13 | 0.14 | 0.83 | 0.18 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | -4.04 | 4.02 | 6.38 | 7.17 | 6.07 |
| PBIT Margin (%) | -4.23 | 3.98 | 6.37 | 7.10 | 5.97 |
| PBT Margin (%) | -8.96 | 2.49 | 4.02 | 3.20 | 1.24 |
| Net Profit Margin (%) | -9.08 | 1.96 | 3.35 | 3.20 | 0.76 |
| NP After MI And SOA Margin (%) | -9.08 | 1.96 | 3.35 | 3.20 | 0.76 |
| Return on Networth / Equity (%) | -17.00 | 11.79 | 14.62 | 9.53 | 2.38 |
| Return on Capital Employeed (%) | -4.30 | 15.13 | 20.54 | 12.13 | 18.70 |
| Return On Assets (%) | -4.09 | 2.80 | 2.66 | 2.59 | 0.89 |
| Long Term Debt / Equity (X) | 0.84 | 0.57 | 0.35 | 0.74 | 0.00 |
| Total Debt / Equity (X) | 2.18 | 1.11 | 1.95 | 0.79 | 0.11 |
| Asset Turnover Ratio (%) | 0.41 | 1.33 | 0.85 | 0.91 | 0.90 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 1.35 | 1.29 | 1.15 | 1.44 | 0.94 |
| Quick Ratio (X) | 1.11 | 1.13 | 1.01 | 1.08 | 0.82 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | -0.85 | 2.71 | 2.72 | 1.84 | 1.29 |
| Interest Coverage Ratio (Post Tax) (%) | -0.91 | 2.33 | 2.43 | 1.82 | 1.16 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 16.50 | 32.16 | 83.06 | 80.91 | 55.69 |
| EV / Net Operating Revenue (X) | 2.22 | 1.16 | 4.66 | 7.78 | 5.63 |
| EV / EBITDA (X) | -54.93 | 28.71 | 73.00 | 108.40 | 92.67 |
| MarketCap / Net Operating Revenue (X) | 1.07 | 0.97 | 4.22 | 7.26 | 5.28 |
| Price / BV (X) | 2.01 | 5.86 | 18.38 | 21.61 | 16.54 |
| Price / Net Operating Revenue (X) | 1.07 | 0.97 | 4.22 | 7.26 | 5.28 |
| EarningsYield | -0.08 | 0.02 | 0.01 | 0.00 | 0.00 |
